Michael Secora

Insider Reports History

Entity
Individual
Location
C/O Recursion Pharmaceuticals, 41 S. Rio Grande Street, Salt Lake City, UT
Signature
/s/Jonathan Golightly, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Secora:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. Chief Financial Officer Class A Common Stock 1.49M $9.19M $6.18 Nov 15, 2024 Direct
RECURSION PHARMACEUTICALS, INC. Chief Financial Officer Stock Option (Right to Buy) 348K Nov 15, 2024 Direct

Insider Reports Filed by Michael Secora

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RXRX RECURSION PHARMACEUTICALS, INC. Nov 15, 2024 1 -$73.7K 4 Nov 19, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Nov 12, 2024 6 -$54.7K 4 Nov 14, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Oct 8, 2024 6 -$15.3K 4 Oct 10, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Sep 10, 2024 6 -$12.4K 4 Sep 12, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Aug 15, 2024 1 -$80K 4 Aug 19, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Aug 13, 2024 6 -$15.6K 4 Aug 15, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Jul 9, 2024 6 -$43.5K 4 Jul 11, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Jun 13, 2024 6 -$104K 4 Jun 17, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. May 15, 2024 1 -$120K 4 May 17, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Apr 16, 2024 6 -$201K 4 Apr 18, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Mar 12, 2024 6 -$371K 4 Mar 14, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Feb 15, 2024 1 -$89.1K 4 Feb 16, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Feb 13, 2024 7 -$341K 4 Feb 15, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Feb 9, 2024 4 -$25.3K 4 Feb 13, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Jan 16, 2024 6 -$351K 4 Jan 18, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Dec 12, 2023 6 -$208K 4 Dec 14, 2023 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Nov 14, 2023 8 -$226K 4 Nov 16, 2023 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Oct 10, 2023 6 -$182K 4 Oct 12, 2023 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Sep 12, 2023 6 -$261K 4 Sep 14, 2023 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Aug 15, 2023 7 -$331K 4 Aug 17, 2023 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Jul 18, 2023 9 -$563K 4 Jul 19, 2023 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Jun 13, 2023 6 -$334K 4 Jun 15, 2023 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. May 15, 2023 1 -$26.7K 4 May 17, 2023 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Feb 15, 2023 1 -$10.6K 4 Feb 17, 2023 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Feb 1, 2023 4 -$22.8K 4 Feb 3, 2023 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Nov 15, 2022 1 -$12.6K 4 Nov 17, 2022 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Aug 15, 2022 1 -$13.8K 4 Aug 17, 2022 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. May 16, 2022 1 -$6.06K 4 May 18, 2022 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Feb 4, 2022 3 -$7.73K 4/A Apr 28, 2023 Chief Financial Officer